Analysis of hematopoietic chimerism is important for monitoring engraftment, graft failure, and disease recurrence. Although several techniques are now available, their sensitivity is unsatisfactory. In sex-mismatched stem cell transplantation (SCT) with a female donor, Y chromosome-specific sequences have proven the most sensitive marker. However, in the case of a male donor, no such reliable marker has been available to date. In this study, we report a novel method we developed to detect microchimerism in female recipients who receive SCT from male donors. The X-linked human androgen receptor gene (HUMARA) contains a highly polymorphic CAG trinucleotide repeat. Near this polymorphic site are methyl-sensitive HpaII restriction enzyme sites. After HpaII digestion, unmethylated male HUMARA sequences are completely digested, while methylated female ones remain intact among the male origin cells. This allows a highly efficient detection of a small number of female cells. Combined with the nested PCR technique, the X chromosome methylation-based chimerism assay could attain a 10 ؊4 level of sensitivity, which is 1000-fold higher than that of conventional assays. The applicability of the method was confirmed in two transplant cases. This highly sensitive method can also be applied to detect minimal residual disease or microchimerism in conditions other than hematopoietic SCT. Bone Marrow Transplantation (2001) 28, 969-973.
ent and donor cells is detected; and microchimerism, in which only a low level of residual host cells can be detected. The assessment of MC is essential not only in established myeloablative SCT but now also for the recently developed nonmyeloablative SCT; stable MC may indicate mutual donor-host tolerance and measurement of the MC state may be useful for determining the optimum timing of donor lymphocyte infusion. The analysis of highly polymorphic regions in genomes, variable numbers of tandem repeats (VNTR), has been widely used to assess the chimeric status in SCT. [1] [2] [3] [4] [5] Variable numbers of tandem repeats are divided into two types by tandem repeat core size, minisatellite and microsatellite, or short tandem repeats (STRs) with 2 to 5 base repeats. These polymorphic sequences can be amplified by polymerase chain reaction (PCR), which allows rapid assessment from minimal amounts of DNA sample. Although STR analysis has an advantage of independence from sex-mismatch and diseasespecific sequences, its sensitivity is usually low (a few percent), probably due to competition of primers between the major and the minor populations. One of these STR markers, the human androgen receptor (HUMARA) gene, contains a highly polymorphic CAG trinucleotide repeat in the first exon and near this polymorphic site are HpaII or HhaI restriction enzyme sites. 6, 7 These four sites are methylated on the inactivated X chromosome but unmethylated on the activated X chromosome. Human androgen receptorbased methylation analysis, which works on the same principles as G-6-PD isoenzyme analysis, was originally developed to investigate clonality. [8] [9] [10] [11] When SCT is performed with a male donor and a female recipient, a few female cells will be surrounded by a large number of male cells (Figure 1 ). Male HUMARA sequences, however, are always on an active X chromosome, which is completely digested by methyl-sensitive restriction enzymes including HpaII. Thus, after digestion by HpaII, only digestion-resistant HUMARA genes on inactivated X chromosomes remain, allowing amplification of a small number of female-derived sequences. In sexmismatched SCT with a female donor and a male recipient, Y chromosome-specific DNA detection has been shown to be most efficient for finding residual male-derived cells. [12] [13] [14] However, in the male donor and female recipient combination, no such useful marker has been available so far. Thus, we have developed this novel HUMARA-based Methyl-sensitive restriction enzyme digestion Figure 1 The strategy of our HUMARA-chimerism assay. All activated male X chromosomes are digested by a methyl-sensitive restriction enzyme such as HpaII. After digestion, only HUMARA sequences on an inactivated female allele can be amplified by PCR. Spotted shading represents a male X chromosome. Dark shading represents an activated female X chromosome. Light shading represents an inactivated female X chromosome. chimerism analysis method and tested the applicability on two allogeneic SCT cases with female recipients and male donors. The key step in the procedure is the methylation sensitive digestion of the male HUMARA allele, thus increasing the sensitivity of detection of the female cells.
Materials and methods

Patient 1
In July 2000, a 21-year-old female patient with CML in the chronic phase underwent unmanipulated allogeneic peripheral blood SCT from a 26-year-old male first cousin with a one-locus HLA mismatch. The conditioning regimen was total body irradiation (TBI) at 12 Gy and cyclophosphamide (CY) at 50 mg/kg/day for 2 days. A total of 4.8 ϫ 10 6 cells/kg CD34 ϩ cells in G-CSF-mobilized mononuclear cells was infused. For prophylaxis against GVHD, cyclosporin A (CsA), short-term administration of methotrexate (MTX), and methylprednisolone (mPSL) were given. Thrombotic microangiopathy (TMA) was diagnosed on day 13, and grade III acute GVHD followed on day 20. The patient died on day 75 from hepatic failure complicated with a GVHD and TMA recurrence, and a simultaneous cytomegalovirus (CMV) infection.
Patient 2
In August 2000, a 47-year-old female patient with AML-M4 with eosinophilia in second CR received unmanipulated allogeneic peripheral blood SCT from a 49-year-old HLAmatched brother. Her conditioning regimen consisted of TBI and CY. A total of 4.4 ϫ 10 6 cells/kg CD34 ϩ cells was infused. GVHD prophylaxis consisted of CsA and short-term MTX. Grade I GVHD was observed on day 14. After administration of mPSL, the GVHD immediately regressed. Chronic GVHD involving the skin and eyes occurred on day 237.
Sample preparations
Peripheral blood nucleated cells were obtained from these two female patients at consecutive time points and from their related healthy male donors before hematopoietic SCT. Each DNA sample was isolated using a SepaGene DNA extraction kit (Sanko, Tokyo, Japan) according to the manufacturer's instructions. Female recipient and male donor DNA samples were prepared in duplicate; one was digested with 30 U HpaII and 10 U RsaI (Takara, Kyoto, Japan) and the other was digested with only RsaI in a total volume of 20 l for 12 h at 37°C. Various dilutions of normal female and male DNA were also used to estimate the sensitivity of this method. After digestion, the reaction was terminated by incubating the mixture at 95°C for 5 min.
DNA fragment amplification and detection
Analysis of fluorescent PCR products on an automated gene analyzer was performed according to the method described in our previous publication with some modifications. 15 In this study, the nested PCR approach was added to the single PCR analysis to increase the sensitivity. Because of the high GC content of the HUMARA gene, 16 PCR was performed using a GC-rich PCR system (Roche, Indianapolis, IN, USA). Briefly, 2 l of the 20 l digestion sample was added to 40 l PCR reaction solution containing 200 m dNTPs, 4 l GC solution, and 10 pmol of each oligonucleotide primer. After denaturation at 94°C for 7 min, 35 cycles of amplification (94°C for 45 s, 55°C for 30 s, 72°C for 45 s) were run and a long final extension step (72°C for 15 min) was performed to facilitate terminal deoxynucleotidyl transferase-mediated dATP addition, avoiding a one-base mobility shift which might influence the resolution capability of this method. The following oligonucleotide primers were prepared: AR24F 5Ј-GGT AAG GGA AGT AGG TGG AAG ATT C-3Ј, AR457R 5Ј-TCT GGG ACG CAA CCT CTC TC-3Ј, HUMAR 5Ј-(FAM) TCC AGA ATC TGT TCC AGA GCG TGC-3Ј, and HUMI 5Ј-GCT GTG AAG GTT GCT GTT CCT CAT-3Ј. The HUMAR/HUMI primers were produced according to Tilley and colleagues 6 and the AR24F/AR457R pairs were designed by Primer Express software (Applied Biosystems, Foster City, CA, USA). The 5Ј end of the HUMAR primer was labeled with FAM fluorescent dye. Single PCR was performed with the HUMAR/HUMI primers. For nested PCR, 2 l of the first round PCR products amplified with AR24F/AR457R primers was used as a template in the second PCR with the HUMAR/HUMI primers, comprising the same PCR condition as described above. All PCR products were electrophoresed on an ABI/Prism 310 Genetic Analyzer and analyzed with GeneScan Analysis Software (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions.
Results
Sensitivity of the method
Normal female DNA diluted in 2 g of normal male DNA at ratios from 1:1 to 1:10 Ϫ5 was amplified in triplicate to determine the sensitivity of the assay (Figure 2 ). Single PCR analysis without HpaII digestion, which corresponds to the conventional PCR-based STR assay, detected HUM-ARA peaks derived from female DNA at 10 Ϫ1 level but failed at 10 Ϫ2 (Figure 2a ). After HpaII digestion, a 10
Ϫ3
level of sensitivity was attained by single PCR analysis with HpaII digestion (Figure 2b ). Nested PCR analysis without digestion had a 10 Ϫ2 to 10 Ϫ3 level of sensitivity (Figure 2c) , while nested PCR analysis with HpaII digestion increased the sensitivity to the 10 Ϫ4 level (Figure 2d ). Thus, the nested PCR and methyl-sensitive restriction enzyme strategies allow for a sensitivity increase of approximately 1000 times compared with the conventional HUMARA assay. In the situation of a very low amount of female DNA (Figure 2d ), an unexpected residual HUM-ARA peak derived from male cells was found which might interfere with the detection of female DNA. This peak may have been caused by partial digestion of HpaII, although repeated digestions did not change the result, or by incomplete demethylation of the CpG sites of the HUMARA first exon on an active X chromosome, which should be completely unmethylated.
Chimerism after stem cell transplantation
We mixed various concentrations of the recipient female's DNA with 2 g of the donor male's DNA to evaluate the Both of the patients showed MC in samples taken at all the time points when examined by nested PCR after HpaII digestion. Although patient 1 had severe GVHD resulting in death, all of her samples showed MC. Host chimerism was detected from a peripheral blood sample on day 6 when her white blood cell count fell below the detection level (Figure 3a) . Although no complete donor chimerism was obtained in a sequential sample until day 160 in patient 2, relapse of leukemia had not been observed until day 240, the end of the follow-up period (Figure 3b) .
Discussion
We established a HUMARA-based chimerism assay for female hosts who undergo sex-mismatched allogeneic SCT. This method has several advantages. First, digestion of male-derived genes on active X chromosomes makes it possible to detect even a very small number of female cells among a great number of male cells. This strategy has been shown to allow identification of residual host-derived bands after SCT. Second, high resolution is achieved by analysis of fluorescent PCR products on an automated gene analyzer, 17, 18 which is sensitive enough to discern a one-base difference. We used a GC-rich PCR system because amplification of GC-rich targets such as the HUMARA gene has proved difficult. 16 Third, most female recipient/male donor pairs can be assessed by one gene because almost 90% of females are heterozygous for the HUMARA gene. 15, [19] [20] [21] Reverse transcription-PCR (RT-PCR) analysis of diseasespecific sequences, including BCR-ABL or PML-RAR␣ fusion genes, is highly sensitive (10 Ϫ4~1 0
Ϫ6
) and real-time quantitative methods have recently been developed using these disease-specific markers; however, this method still has limited applications. We investigated chimerism in two patients receiving SCT from relatives and each host shared one X chromosome with her donor. In SCT from siblings, theoretically, 50% of children share the same paternal or maternal X chromosome. If the host shares one chromosome with the donor and the other X chromosome is completely unmethylated as a result of skewed X inactivation, detection of female host-derived HUMARA products is difficult. Extreme skewing of X inactivation has been reported in about 10% of normal females 15, [19] [20] [21] and the frequency increases with age. 20, 21 Analysis of X inactivation patterns is a useful clonal marker and the HUMARA gene has been widely used for clonal analysis. Thus, this method may be used to identify the clonal nature of residual host cells in some instances, whether derived from the malignant clone or from normal cells. Conversely, this method might make the evaluation of chimerism as troublesome as does X inactivation skewing. To validate the issue, further investigation with additional patients is necessary. This approach may be more feasible in SCT from unrelated donors.
Nested PCR analysis with methyl-sensitive endonuclease digestion led to a 1000-fold increase in sensitivity compared to single PCR analysis without digestion. In a very low female DNA concentration range, a male-derived HUMARA peak was detected even after HpaII digestion. Partial endonuclease digestion or incomplete demethylation of an active X chromosome is suspected to be the cause. Using the HUMARA-based chimerism assay, two patients receiving SCT were analyzed and inactive residual female sequences were detected in the early post-SCT peripheral blood samples. These were probably derived from lymphocytes that had survived the conditioning. The sensitivity was as low as 10 Ϫ3 even by nested PCR analysis in patient 2, who had only one CAG repeat difference between two alleles. The difference in repeat number may be one variable which affects sensitivity.
Although the role of mixed chimerism after SCT is still under discussion, it does not necessarily indicate graft failure or disease progression. Recently developed nonmyeloablative SCT has revealed that tolerance is induced by the establishment of mixed chimerism. [22] [23] [24] Microchimerism has also been detected in patients following liver transplantation. 25 In addition to transplantation, pregnancy is another source of microchimerism. Long-lasting circulating male cells have been found in females bearing male fetuses by detection of amplified Y-specific DNA. The pathogenetic relevance of microchimerism to systemic sclerosis has been proposed. 26, 27 Conversely, HLA-specific PCR analysis has frequently revealed persistent maternal microchimerism in healthy control subjects. 28 This HUMARA-based chimerism assay could be a tool in addition to Y chromosomespecific sequences for estimating microchimerism in sexmismatched situations.
